Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenzhuo He

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Advances in Experimental Medicine and Biology|November 16, 2019
Autophagy Regulation of Mammalian Immune CellsWenzhuo He, Wenjing Xiong, Xiaojun Xia
BMC Cancer|March 9, 2023
Characterisation of tumor microenvironment and prevalence of CD274/PD-L1 genetic alterations difference in colorectal CancerLin Yang, Shousheng Liu, Wenzhuo He, et al.
Frontiers in Nutrition|June 5, 2023
Predictive value of prognostic nutritional and systemic immune-inflammation indices for patients with microsatellite instability-high metastatic colorectal cancer receiving immunotherapyJiahong Yi, Ju Xue, Lin Yang, et al.
Journal of Cancer|June 23, 2017
The Prognostic and Predictive Value of Carbohydrate Antigen 19-9 in Metastatic Colorectal Cancer Patients with First Line Bevacizumab Containing ChemotherapyChang Jiang, Shousheng Liu, Wenzhuo He, et al.
Immunotargets and Therapy|October 21, 2024
Assessing the Prognostic Value of 13 Inflammation-Based Scores in Patients with Unresectable or Advanced Biliary Tract Carcinoma After ImmunotherapyFang Wang, Chang Jiang, Wenzhuo He, et al.
Oncology Letters|October 23, 2020
Efficacy and mechanism of combination of oxaliplatin with PKM2 knockdown in colorectal cancerChenxi Yin, Wenhua Lu, Mingzhe Ma, et al.
Cancer Immunology, Immunotherapy : CII|January 29, 2021
The predictive value of body mass index on prognosis and adverse events of cancers treated with immunotherapy: a systematic review and meta-analysisYafei You, Chang Jiang, Kunwei Peng, et al.
BMC Cancer|December 22, 2017
Clinical baseline and prognostic difference of platelet lymphocyte ratio (PLR) in right-sided and let-sided colon cancersLin Yang, Wenzhuo He, Pengfei Kong, et al.
Frontiers in Oncology|December 7, 2020
Previous Use of Anti-Vascular Endothelial Growth Factor Receptor Agents Decreases Efficacy of Fruquintinib in Metastatic Colorectal Cancer Refractory to Standard TherapiesLei Wang, Huijiao Cao, Chang Jiang, et al.
Journal of Cancer|July 2, 2019
Metastatic lymph node ratio as a prognostic indicator in patients with stage IV colon cancer undergoing resectionChang Jiang, Fang Wang, Guifang Guo, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Advances in Experimental Medicine and Biology|November 16, 2019
Autophagy Regulation of Mammalian Immune CellsWenzhuo He, Wenjing Xiong, Xiaojun Xia
BMC Cancer|March 9, 2023
Characterisation of tumor microenvironment and prevalence of CD274/PD-L1 genetic alterations difference in colorectal CancerLin Yang, Shousheng Liu, Wenzhuo He, et al.
Frontiers in Nutrition|June 5, 2023
Predictive value of prognostic nutritional and systemic immune-inflammation indices for patients with microsatellite instability-high metastatic colorectal cancer receiving immunotherapyJiahong Yi, Ju Xue, Lin Yang, et al.
Journal of Cancer|June 23, 2017
The Prognostic and Predictive Value of Carbohydrate Antigen 19-9 in Metastatic Colorectal Cancer Patients with First Line Bevacizumab Containing ChemotherapyChang Jiang, Shousheng Liu, Wenzhuo He, et al.
Immunotargets and Therapy|October 21, 2024
Assessing the Prognostic Value of 13 Inflammation-Based Scores in Patients with Unresectable or Advanced Biliary Tract Carcinoma After ImmunotherapyFang Wang, Chang Jiang, Wenzhuo He, et al.
Oncology Letters|October 23, 2020
Efficacy and mechanism of combination of oxaliplatin with PKM2 knockdown in colorectal cancerChenxi Yin, Wenhua Lu, Mingzhe Ma, et al.
Cancer Immunology, Immunotherapy : CII|January 29, 2021
The predictive value of body mass index on prognosis and adverse events of cancers treated with immunotherapy: a systematic review and meta-analysisYafei You, Chang Jiang, Kunwei Peng, et al.
BMC Cancer|December 22, 2017
Clinical baseline and prognostic difference of platelet lymphocyte ratio (PLR) in right-sided and let-sided colon cancersLin Yang, Wenzhuo He, Pengfei Kong, et al.
Frontiers in Oncology|December 7, 2020
Previous Use of Anti-Vascular Endothelial Growth Factor Receptor Agents Decreases Efficacy of Fruquintinib in Metastatic Colorectal Cancer Refractory to Standard TherapiesLei Wang, Huijiao Cao, Chang Jiang, et al.
Journal of Cancer|July 2, 2019
Metastatic lymph node ratio as a prognostic indicator in patients with stage IV colon cancer undergoing resectionChang Jiang, Fang Wang, Guifang Guo, et al.
Pageof 5